NR5A2 and focal segmental glomerulosclerosis: We subsequently wondered whether perilipin-2 expression was also increased in glomeruli of patients with (recurrent) FSGS, as this could suggest perilipin-2 to be involved in pathogenesis in vivo, next to being an in vitro (bio)marker of CPF presence.